Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 120.67
   
  • Change Today:
    $-3.68
  • 52 Week High: $128.07
  • 52 Week Low: $89.14
  • Currency: US Dollars
  • Shares Issued: 1,246.00m
  • Volume: 6,712,728
  • Market Cap: $150,355m
  • RiskGrade: 120

Latest ShareCast News

GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill

By Frank Prenesti

Date: Thursday 23 Feb 2023

(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 120.67
Change Today $ -3.68
% Change -2.96 %
52 Week High $128.07
52 Week Low $89.14
Volume 6,712,728
Shares Issued 1,246.00m
Market Cap $150,355m
RiskGrade 120

What The Brokers Say

Strong Buy 9
Buy 13
Neutral 6
Sell 1
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 08-Jan-2026

Time Volume / Share Price
16:00 1,200,171 @ $120.67
15:59 123 @ $120.65
15:59 200 @ $120.65
15:59 182 @ $120.65
15:59 100 @ $120.65

Top of Page